Intravenous lidocaine for treatment-resistant pruritus

American Journal of Medicine

Volumn 102, Issue 6, 1997, Pages 584-585

  Fishman, Scott M ^a   Caneris, Onassis A ^a   Stojanovic, Milan P ^a   Borsook, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BILE ACID; CYCLOSPORIN; DANAZOL; LIDOCAINE; NALOXONE; ONDANSETRON; PROPOFOL; SODIUM CHANNEL; SODIUM ION;

ADULT; ARTICLE; CASE REPORT; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMODULATION; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RECEPTOR BLOCKING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRYPTOSPORIDIOSIS; HUMANS; INJECTIONS, INTRAVENOUS; LIDOCAINE; MALE; PRURITUS;

EID: 0030844475     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00057-0     Document Type: Article

References (19)

1. Wahlgren CF. Measurement of itch. Sem Dermatol. 1995;14(4):277-284.
2. Lorette G, Vaillant L. Pruritus. Current concepts in pathogenesis and treatment. Drugs. 1990;39(2):218-223.
3. McMahon SB, Koltzenburg M. Itching for an explanation. Neurology. 1991;41:1024-1028.
4. Yao GL, Tohyama M, Senba E. Histamine-caused itch induces Fos-like immunoreactivity in dorsal horn neurons: effect of morphine pretreatment. Brain Research. 1992;599:333-337.
5. Rowbotham MC, Reisner LM, Fields HL. Both intravenous lidocaine and morphine reduce the pain of post herpetic neuralgia. Neurology. 1991;41:1024-1028.
6. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesthesiology. 1996;82:91-97.
7. Jones EA, Bergasa NV. Why do cholestatic patients itch? Gut. 1996;38:644-645.
8. Evans PR. Referred itch. BMJ. 1976;2(6040):839-841.
9. Green BG, Shaffer GS. The sensory response to capsaicin during repeated topical exposures: differential effects on sensations of itching and pungency. Pain. 1993;53(3):3223-3234.
10. Lynn B. Capsaicin: actions on C fibre afferents that may be involved in itch. Skin Pharmacol. 1992;5(1):9-13.
11. Culp WJ, Ochoa J, Cline M, Dotson R. Heat and mechanical hyperalgesia induced by capsaicin. Cross modality threshold modulation in human C nociceptors. Brain. 1989;112(pt 5):1317-1331.
12. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociptor-driven spinal sensitization in the rat. Anesthesiology. 1994;80(2):383-391.
13. Edwards WT, Habib F, Burney RG, Begin G. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Reg Anesthesia. 1985;10:1-6.
14. Rowbothan MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
15. Saiah M, Borgeat A, Wilder-Smith OHG, et al. Epidural-morphine-induced pruritus: propofol versus naloxone. Anesth Analges. 1994;78:1110-1113.
16. Shwoner H, Hertman H, Ramadori G. Relief of didestatic pruritus by a novel class of drug: 5 hydroxytryptamine type 3 (5HT3) receptor antagonists; effectiveness of ondansetron. Pain. 1995;661:33-37.
17. Kendrick WD, Woods AM, Daly MY, et al. Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus. Anesth Analges. 1996;82:641-647.
18. Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Dermato-Venereologica. 1990;70(4):323-329.
19. Kolodny I, Horstman LL, Sevin BU, et al. Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases. Am J Hematol. 1996;51(2):112-116.